Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Rev Esp Anestesiol Reanim (Engl Ed) ; 68(2): 114-116, 2021 Feb.
Article in English, Spanish | MEDLINE | ID: mdl-33371977
2.
Article in Spanish | IBECS | ID: ibc-196755
3.
Rev. esp. anestesiol. reanim ; 67(5): 253-260, mayo 2020. ilus, tab
Article in Spanish | IBECS | ID: ibc-186843

ABSTRACT

En diciembre del 2019, la Comisión Municipal de Salud y Sanidad de Wuhan (provincia de Hubei, China) informó de una serie de casos de neumonía de etiología desconocida. El 7 de enero del 2020, las autoridades chinas identificaron como agente causante del brote un nuevo tipo de virus de la familia Coronaviridae, denominado SARS-CoV-2. Desde entonces, se han notificado miles de casos con una diseminación global. Las infecciones en humanos provocan un amplio espectro clínico que va desde infección leve del tracto respiratorio superior, hasta síndrome de distrés respiratorio agudo grave y sepsis. No existe un tratamiento específico para SARS-CoV-2, motivo por lo que los aspectos fundamentales son establecer medidas adecuadas de prevención y el tratamiento de soporte y manejo de las complicaciones


In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications


Subject(s)
Humans , Coronavirus Infections/complications , Severe acute respiratory syndrome-related coronavirus/pathogenicity , Coronavirus/pathogenicity , Surgical Procedures, Operative/methods , Universal Precautions/methods , Perioperative Care/methods , Severe acute respiratory syndrome-related coronavirus/classification , Disease Transmission, Infectious , Practice Patterns, Physicians' , Safety Management/methods
4.
Rev Esp Anestesiol Reanim (Engl Ed) ; 67(5): 253-260, 2020 May.
Article in English, Spanish | MEDLINE | ID: mdl-32197787

ABSTRACT

In December 2019, the Wuhan Municipal Health and health Commission (Hubei Province, China) reported a series of cases of pneumonia of unknown etiology. On January 7, 2020, the Chinese authorities identified as a causative agent of the outbreak a new type of virus of the Coronaviridiae family, called SARS-CoV-2. Since then, thounsands of cases have been reported with global dissemination. Infections in humans cause a broad clinical spectrum ranging from mild upper respiratory tract infection, to severe acute respiratory distress syndrome and sepsis. There is not specific treatment for SARS-CoV-2, which is why the fundamental aspects are to establish adequate prevention measures and support treatment and management of complications.


Subject(s)
Betacoronavirus , Coronavirus Infections/therapy , Perioperative Care/methods , Pneumonia, Viral/therapy , COVID-19 , China , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Disease Management , Humans , Pandemics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , SARS-CoV-2
5.
Transplant Proc ; 47(8): 2324-7, 2015 Oct.
Article in English | MEDLINE | ID: mdl-26518917

ABSTRACT

BACKGROUND: Donors after brain death (DBD) older than 60 years have become 46.8% of our current activity, with higher risk of renal discard rate (RDR). Assessment of kidney suitability requires complementary strategies: macroscopic evaluation, kidney biopsy score (KBS), and renal hemodynamic evaluation with the Pulsatile Perfusion Machine (PPM). METHODS: Descriptive, cross-sectional, comparative study of kidneys procured and RDR, comparing 3 time periods: 2000 to June 2004, when only KBS were used; July 2004 to 2008 (introduction of PPM and learning period); and 2009 to 2013 (experienced use of PPM). Transplantation criteria were KBS <3 and PPM renal resistance <0.4 mm Hg/mL/min and arterial renal flow >70 mL/min. RESULTS: Between 2000 and 2013, a 59.2% reduction in DBD kidneys was observed. However, older kidneys had an increase from 33.5% to 46.8%. The RDR had increased, comparing the first to the third period from 25.4% to 38.3%. However, the RDR was lower when kidneys were evaluated with PPM than those evaluated only with KBS and preserved in cold storage (CS) (21.4% versus 43.7%). There was a significant difference in cold ischemia time, because CS kidney was grafted before PPM. During the third period, more kidneys with KBS ≥4 were assigned to PPM. CONCLUSIONS: Notwithstanding the decrease in DBD-procured kidneys and the increase in older kidneys during last period, the use of PPM allowed low DR compared with CS. A bias in the results of PPM could be generated when kidneys with higher KBS were excluded from PPM. The use of KBS only to decide acceptance could preclude the use of an additional tool to evaluate suitability.


Subject(s)
Brain Death/physiopathology , Kidney Transplantation , Organ Preservation , Pulsatile Flow/physiology , Age Factors , Aged , Cross-Sectional Studies , Cryopreservation , Humans , Middle Aged , Tissue Donors , Tissue and Organ Procurement
6.
Rev Esp Anestesiol Reanim ; 51(7): 399-402, 2004.
Article in Spanish | MEDLINE | ID: mdl-15495640

ABSTRACT

A 17-year-old male suffered severe noncardiogenic pulmonary edema with arterial hypotension and acute renal insufficiency after withdrawal of a central venous catheter from the subclavian vein. The patient was in semirecumbent supine position with the head of the bed at a 40 degree angle. Resuscitation maneuvers, orotracheal intubation, and hemodynamic support were required. After 4 days in intensive care the patient had fully recovered. Fibrin tracts form around catheters and can create a way for air to enter a vein after catheter removal. The causes of pulmonary edema secondary to venous air embolism have been well studied: it seems that edema develops as a consequence of the sudden appearance of small air bubbles in pulmonary circulation, leading to an acute inflammatory response in pulmonary microvasculature. Experimental studies have shown that edema is associated with increased pulmonary vascular resistance that leads to pulmonary hypertension. Venous air embolism as a complication of central venous catheterization is too seldom detected and little stress is placed on this possibility in the care and removal of catheters.


Subject(s)
Acute Kidney Injury/etiology , Catheterization, Central Venous/adverse effects , Pulmonary Edema/etiology , Adolescent , Humans , Male
SELECTION OF CITATIONS
SEARCH DETAIL
...